Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018222798) X-RAY PSORALEN ACTIVATED CANCER THERAPY (X-PACT) WITH ASSOCIATED TREATMENTS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/222798 International Application No.: PCT/US2018/035279
Publication Date: 06.12.2018 International Filing Date: 31.05.2018
IPC:
A61N 5/06 (2006.01) ,A61B 6/00 (2006.01) ,A61K 9/00 (2006.01) ,A61K 49/04 (2006.01) ,A61N 5/10 (2006.01)
[IPC code unknown for A61N 5/06][IPC code unknown for A61B 6][IPC code unknown for A61K 9][IPC code unknown for A61K 49/04][IPC code unknown for A61N 5/10]
Applicants:
IMMUNOLIGHT, LLC [US/US]; 1901 St. Antoine Street 6th Floor at Ford Field Detroit, MI 48226, US
DUKE UNIVERSITY [US/US]; 2020 W. Main Street, Suite 10 Durham, NC 27705, US
Inventors:
BOURKE, Frederic A.; US
DEWHIRST, Mark; US
SPECTOR, Neil; US
YOON, Paul; US
ADAMSON, Justus; US
ALCORTA, David; US
LYERLY, Kim; US
LIU, Leihua; US
OSADA, Takuya; US
OLDHAM, Mark; US
FATHI, Zakaryae; US
BEYER, Wayne F.; US
WALDER, Harold; US
Agent:
MASON, J., Derek; US
Priority Data:
62/512,97431.05.2017US
Title (EN) X-RAY PSORALEN ACTIVATED CANCER THERAPY (X-PACT) WITH ASSOCIATED TREATMENTS
(FR) RADIOTHÉRAPIE ANTICANCÉREUSE ACTIVÉE PAR DU PSORALÈNE (X-PACT) ASSORTIE DE TRAITEMENTS ASSOCIÉS
Abstract:
(EN) A system (and associated method) for treating a human or animal body. The system has a photoactivatable drug for treating a first diseased site, a first pharmaceutically acceptable carrier including one or more phosphorescent or fluorescent agents which are capable of emitting an activation energy into the body which activates the photoactivatable drug, a first device which infuses the first diseased site with a photoactivatable drug and the first pharmaceutically acceptable carrier, a first energy source which irradiates the diseased site with an initiation energy to thereby initiate emission of the activation energy into the body, and a supplemental treatment device which administers one or both of a therapeutic drug or radiation to the body at a second diseased site or the first diseased site, to provide an immune system stimulation in the body.
(FR) L'invention concerne un système (et une méthode associée) de traitement d'un corps humain ou animal. Le système comprend un médicament photoactivable permettant de traiter un premier site malade, un premier support pharmaceutiquement acceptable comprenant un ou plusieurs agents phosphorescents ou fluorescents qui sont capables d'émettre une énergie d'activation dans le corps, laquelle active le médicament photoactivable, un premier dispositif qui introduit par perfusion dans le premier site malade le médicament photoactivable et le premier support pharmaceutiquement acceptable, une première source d'énergie qui expose le site malade à une énergie d'amorçage de sorte à amorcer l'émission de l'énergie d'activation dans le corps, et un dispositif de traitement supplémentaire qui administre au corps un médicament et/ou un rayonnement thérapeutiques au niveau d'un second site malade ou du premier site malade, pour produire une stimulation du système immunitaire dans le corps.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)